Hepatic Cyst (Simple Liver Cyst) — a benign fluid-filled cystic lesion arising within the liver parenchyma, representing the most common benign hepatic mass with a prevalence of approximately two to seven percent in the general population and a female predominance in symptomatic presentations, classified as congenital or developmental in origin due to aberrant development of intrahepatic bile ducts that form isolated epithelium-lined cysts that do not communicate with the biliary system, distinguished from polycystic liver disease in which numerous hepatic cysts occur in association with autosomal dominant polycystic kidney disease, and from cystic biliary hamartomas or von Meyenburg complexes which are small clustered bile duct microhamartomas, and from complex hepatic cysts or cystic hepatic neoplasms requiring more aggressive evaluation — presenting in the majority of cases as an incidental finding on abdominal ultrasound, CT, or MRI performed for unrelated clinical indications, with imaging features that are classically diagnostic including a thin imperceptible wall without internal septations, nodularity, or mural enhancement, anechoic internal content with posterior acoustic enhancement on ultrasound, and homogeneous low-attenuation content following water density on CT without contrast enhancement, and with clinical symptoms developing in a minority of patients harboring large cysts exceeding five to ten centimeters in diameter where mass effect generates right upper quadrant fullness or discomfort, early satiety from gastric displacement, nausea, abdominal distension, or rarely obstructive jaundice from compression of the extrahepatic bile ducts, with acute presentations from intracystic hemorrhage causing sudden pain and cyst enlargement, cyst rupture into the peritoneal cavity with bile-free cystic fluid causing chemical peritonitis in rare cases, secondary cyst infection complicating prior intervention or occurring spontaneously, and cyst torsion in pedunculated cysts with a narrow stalk. The diagnostic evaluation of hepatic cysts is predominantly imaging-based, with abdominal ultrasound serving as both the typical initial detection modality and the definitive diagnostic tool for classic simple hepatic cysts demonstrating all characteristic ultrasound features, supplemented by contrast-enhanced CT or MRI when ultrasound findings are atypical, when the cyst is large and multiseptate, or when biliary cystadenoma, cystic hepatocellular carcinoma, cystic metastases, or hydatid cyst must be excluded; the Bosniak classification developed for renal cysts has been adapted for hepatic cysts in some centers to stratify complex cysts by malignancy risk based on imaging features; management of simple hepatic cysts is expectant with no treatment required for asymptomatic cysts regardless of size, while symptomatic or complicated cysts are managed by ultrasound-guided or laparoscopic fenestration, sclerotherapy with injection of ethanol or tetracycline into the cyst cavity, or laparoscopic cyst deroofing, with recurrence rates depending on the technique employed.
Hepatic Cyst technology platforms — whether supporting general hepatology and liver imaging platforms providing the diagnostic imaging infrastructure for the initial detection, characterization, and surveillance of simple hepatic cysts that represent the most common hepatic mass in clinical practice; radiology and abdominal imaging platforms delivering the ultrasound, CT, and MRI studies that establish the diagnosis, exclude complex or malignant alternative diagnoses, and guide management decisions for the minority of patients who develop symptomatic large cysts requiring intervention; interventional radiology platforms coordinating the ultrasound-guided sclerotherapy and cyst aspiration procedures that treat symptomatic simple hepatic cysts without requiring operative management; minimally invasive surgery and laparoscopy platforms supporting the laparoscopic cyst fenestration and deroofing procedures that provide durable symptom relief for large symptomatic cysts where sclerotherapy has failed or is technically unsuitable; hepatology gastroenterology platforms managing patients with hepatic cysts occurring in the context of polycystic liver disease where monitoring for progressive hepatomegaly, portal hypertension complications, and associated polycystic kidney disease dominates the longitudinal care; emergency medicine platforms activated for acute hepatic cyst complications including intracystic hemorrhage, cyst infection, pedunculated cyst torsion, and rare cyst rupture; and patient communication platforms delivering the reassurance education, surveillance imaging guidance, and symptom monitoring instructions for the large majority of patients with asymptomatic simple hepatic cysts who require only expectant management with periodic imaging — must maintain the availability and performance standards that hepatic imaging characterization, malignancy exclusion, interventional radiology procedure coordination, laparoscopic surgical planning, polycystic liver disease surveillance, emergency complication management, and patient education demand. This guide explains why Hepatic Cyst tech platforms need dedicated monitoring, what components to monitor, and how to build a monitoring strategy that matches the abdominal imaging, malignancy risk stratification, interventional radiology, laparoscopic surgery, polycystic liver disease management, emergency care, and patient communication demands of modern Hepatic Cyst care.
Why Hepatic Cyst Tech Platforms Require Specialized Monitoring Attention
Hepatic Cyst management is defined by three platform-dependent priorities that reflect the condition's extreme prevalence making it the most commonly encountered hepatic mass in clinical imaging practice, the diagnostic imperative to exclude malignant alternative diagnoses in cysts with atypical or complex imaging features, and the clinical and interventional management pathway activated for the minority of patients with large symptomatic cysts: the requirement for diagnostic radiology platforms capable of delivering high-quality ultrasound, CT, and MRI imaging with sufficient resolution to characterize all features of simple hepatic cysts and identify the complex features that trigger further workup; the interventional radiology and surgical platforms supporting the sclerotherapy, aspiration, and laparoscopic fenestration procedures that definitively manage symptomatic cysts; and the polycystic liver disease monitoring platforms providing the surveillance infrastructure for patients with hepatic cysts in the context of systemic polycystic disease.
Diagnostic imaging platforms define the hepatic cyst diagnosis and management pathway. Ultrasound platforms delivering real-time abdominal imaging for hepatic cyst detection and characterization (thin imperceptible wall, anechoic content, posterior acoustic enhancement, absence of internal echoes, septations, or mural nodularity confirming simple cyst diagnosis versus complex cyst features requiring CT or MRI), CT and MRI platforms providing contrast-enhanced characterization for atypical or complex hepatic cysts (enhancement pattern, internal architecture, communication with biliary system, adjacent vascular involvement, perilesional parenchymal changes, features differentiating biliary cystadenoma from simple cyst, cystic metastasis exclusion, hydatid serology correlation), and surveillance imaging platforms for monitoring known hepatic cysts and polycystic liver disease progression are the diagnostic foundation of hepatic cyst care; failures during an imaging review where a radiologist is characterizing a newly detected four-centimeter hepatic lesion to determine whether its ultrasound features confirm a simple hepatic cyst requiring no further workup or whether internal echogenicity and apparent septation require contrast-enhanced CT for malignancy exclusion prevent the diagnostic workflow that determines whether the patient is reassured and discharged or referred for hepatobiliary oncology evaluation. Monitor diagnostic imaging platforms at 1-minute intervals during active imaging review sessions.
Interventional radiology platforms execute sclerotherapy and aspiration procedures. Interventional radiology guidance platforms providing real-time ultrasound or CT-fluoroscopic visualization during hepatic cyst aspiration and sclerotherapy procedures — where the cyst is accessed under imaging guidance, the cyst fluid is aspirated and submitted for analysis, the cyst cavity is irrigated with sclerosant, and the procedure completion is confirmed by imaging — are the therapeutic infrastructure for symptomatic simple hepatic cysts amenable to percutaneous treatment; failures during an ultrasound-guided sclerotherapy procedure for a symptomatic eight-centimeter right lobe hepatic cyst prevent the interventional radiologist from maintaining real-time visualization of the needle tip position within the cyst cavity during the aspiration and sclerosant instillation, increasing the risk of incomplete aspiration, inadvertent extrahepatic sclerosant injection, and procedure-related complications. Monitor interventional radiology platforms at 1-minute intervals during procedures.
Laparoscopic surgery platforms manage surgical fenestration. Minimally invasive surgical platforms supporting laparoscopic hepatic cyst deroofing and fenestration — where laparoscopic access identifies the cyst dome, the roof of the cyst is excised, the cyst interior is inspected for biliary communication or concerning internal features, and the fenestration margins are assessed for hemostasis — are the operative infrastructure for large or recurrent symptomatic hepatic cysts not amenable to or not controlled by percutaneous sclerotherapy; failures during a laparoscopic hepatic cyst fenestration for a symptomatic twelve-centimeter cyst with prior failed sclerotherapy prevent the surgeon from accessing the intraoperative imaging reference and preoperative MRI demonstrating the cyst relationship to the major hepatic veins and bile ducts that the fenestration must avoid. Monitor laparoscopic surgical platforms at 1-minute intervals during operative sessions.
What to Monitor on a Hepatic Cyst Tech Platform
Diagnostic Radiology and Abdominal Imaging Platforms
Monitor ultrasound records for hepatic cyst detection and characterization (lesion size, wall characteristics, internal content, posterior acoustic enhancement, absence of septations and nodularity confirming simple cyst diagnosis), CT records for complex cyst evaluation (enhancement pattern, internal architecture, Bosniak-adapted classification, biliary communication assessment, malignancy exclusion features), MRI records for superior soft tissue characterization and biliary anatomy (T2 hyperintense fluid signal, MRCP sequences for biliary communication, hepatobiliary phase enhancement for solid component detection), and diagnostic imaging platforms at 1-minute intervals during imaging review sessions and 2-minute intervals during routine hours. Alert immediately — imaging platform failures during a radiology review session characterizing a newly detected hepatic cyst with borderline complexity features — apparent internal echogenicity on ultrasound, possible thin septa, and a small mural irregularity — where the radiologist is assessing whether these features confirm a simple benign cyst or represent the complex features of a biliary cystadenoma or cystic hepatocellular carcinoma requiring multidisciplinary hepatobiliary oncology evaluation, prevent the differential diagnosis workflow on which the patient's entire subsequent management pathway depends.
Hepatology and Liver Disease Platforms
Monitor hepatology clinic records for simple hepatic cyst surveillance (cyst size stability on serial imaging, symptom assessment for new right upper quadrant fullness, early satiety, or discomfort indicating cyst growth to symptom-generating size, documentation of polycystic liver disease versus isolated hepatic cyst), polycystic liver disease management records for patients with autosomal dominant polycystic kidney disease (hepatomegaly progression assessment, portal hypertension screening, renal function monitoring, systemic disease coordination), and hepatology platforms during clinic and telemedicine hours. Alert on sustained failures — hepatology platform outages prevent the hepatologist from accessing prior imaging records for a patient with known polycystic liver disease presenting with increasing abdominal distension and early satiety, where the prior CT measurements are needed to assess whether hepatomegaly has progressed to the degree requiring escalation from watchful waiting to surgical or transplantation evaluation.
Interventional Radiology Platforms
Monitor interventional radiology procedure records for hepatic cyst aspiration and sclerotherapy (pre-procedure imaging confirming target cyst localization and adjacent vascular and biliary anatomy, real-time ultrasound guidance records during aspiration, cyst fluid volume aspirated and character, sclerosant volume instilled, post-procedure imaging confirming cyst decompression, and complication assessment including bile leak, hemorrhage, and peritoneal sclerosant spillage), and interventional radiology platforms at 1-minute intervals during procedural hours. Alert immediately — interventional radiology platform failures during an ultrasound-guided hepatic cyst sclerotherapy procedure for a large symptomatic cyst in a patient who developed right shoulder pain and abdominal fullness from a subcapsular eight-centimeter cyst exerting diaphragmatic pressure prevent the interventional radiologist from maintaining real-time needle tip visualization during aspiration and sclerosant instillation, and from accessing the pre-procedure MRI confirming the cyst is not in communication with the right hepatic duct — the most important pre-procedure exclusion criterion for hepatic cyst sclerotherapy.
Minimally Invasive Surgery Platforms
Monitor laparoscopic surgical records for hepatic cyst deroofing and fenestration (preoperative hepatic imaging demonstrating cyst relationship to major hepatic veins and bile ducts, operative records for cyst roof excision and margin hemostasis, bile communication assessment on cyst interior inspection, intraoperative biliary leak detection, and completeness of fenestration assessment), and surgical platforms at 1-minute intervals during operative sessions. Alert immediately — surgical platform failures during a laparoscopic hepatic cyst fenestration for a fourteen-centimeter left lobe cyst causing biliary obstruction prevent the surgeon from accessing the preoperative MRCP demonstrating the precise relationship between the cyst posterior wall and the left hepatic duct, information critical to determining the safe fenestration margin without inadvertent left hepatic duct injury.
Emergency Medicine Platforms
Monitor emergency department records for acute hepatic cyst complications (intracystic hemorrhage presenting with sudden right upper quadrant pain and cyst enlargement on imaging, secondary cyst infection with fever and right upper quadrant tenderness requiring aspiration and antibiotic management, pedunculated cyst torsion with peritoneal signs, rare cyst rupture with peritoneal fluid accumulation), emergency imaging interpretation records for acute hepatic cyst presentations, and emergency medicine platforms at 1-minute intervals during acute presentations. Alert immediately — emergency medicine platform failures during the evaluation of a patient with known hepatic cysts presenting with acute-onset severe right upper quadrant pain and hemodynamic instability where CT demonstrates a large complex-appearing hepatic cyst with internal hyperdensity suggesting intracystic hemorrhage prevent the emergency physician from accessing the prior imaging to determine whether the intracystic hemorrhage represents spontaneous hemorrhage into a previously simple cyst or complication of a previously complex lesion, information that determines the urgency and extent of the surgical or interventional response.
Patient Communication and Surveillance Platforms
Monitor patient portal records for hepatic cyst expectant management (surveillance imaging schedule for known simple hepatic cysts with interval recommendations based on cyst size, reassurance communication regarding benign diagnosis and low complication risk, symptom monitoring instructions for new or worsening right upper quadrant fullness and early satiety that would prompt clinical evaluation, and guidance on indications for intervention including symptomatic large cysts and complicated presentations), and patient communication platforms during business and evening hours. Alert on sustained failures — patient portal outages prevent a patient with a newly incidentally detected six-centimeter simple hepatic cyst from accessing the reassurance education confirming the benign diagnosis, the explanation that no treatment is required for an asymptomatic cyst regardless of size, and the symptom guide identifying the right upper quadrant fullness, early satiety, and shoulder pain that would warrant clinical evaluation if they develop.
Authentication and Clinical Identity
Monitor authentication at 1-minute intervals, 24/7. Hepatic Cyst programs coordinate across hepatology, diagnostic radiology, interventional radiology, minimally invasive surgery, emergency medicine, and patient communication platforms — authentication failures block access to the imaging library essential to simple versus complex cyst differentiation and malignancy exclusion, the interventional radiology guidance platforms during sclerotherapy, the surgical planning records during laparoscopic fenestration, and the emergency imaging access required during acute intracystic hemorrhage evaluations.
SSL Certificates
Monitor SSL certificate expiry across all diagnostic imaging platforms, interventional radiology systems, surgical planning platforms, emergency medicine systems, hepatology clinic systems, and patient portal systems. Certificate errors disrupt imaging review workflows for hepatic cyst characterization and malignancy exclusion, interventional radiology procedure guidance access, surgical planning record retrieval, emergency acute complication management, and patient reassurance communication regarding the benign prognosis of simple hepatic cysts.
HIPAA and Data Privacy Considerations
Hepatic Cyst technology platforms handle PHI including abdominal ultrasound, CT, and MRI records characterizing hepatic cysts and documenting their diagnostic features, complex cyst characterization records with malignancy risk stratification, interventional radiology procedure records for sclerotherapy and aspiration including cyst fluid analysis results, laparoscopic surgical records for hepatic cyst fenestration and deroofing, emergency medicine records for acute intracystic hemorrhage and cyst rupture presentations, hepatology clinic records for polycystic liver disease surveillance including systemic disease coordination with nephrology for associated polycystic kidney disease, and patient portal records containing surveillance imaging schedules, reassurance communications, symptom monitoring guidance, and intervention indications.
The particular sensitivity of Hepatic Cyst PHI includes the polycystic liver disease records — which document a hereditary condition associated with autosomal dominant polycystic kidney disease that has implications for renal function, systemic disease management, and genetic family risk that may affect insurance and life planning decisions for the patient and their first-degree relatives — and the complex hepatic cyst characterization records where surveillance decisions and malignancy risk stratification may affect the patient's health insurance coverage and employment circumstances. Technology platforms managing Hepatic Cyst PHI must implement HIPAA Security Rule requirements for availability and integrity. Availability monitoring provides operational documentation relevant to HIPAA Security Rule compliance for hepatology, radiology, interventional radiology, surgery, emergency medicine, and patient communication programs managing Hepatic Cyst care.
Alerting Strategy for Hepatic Cyst Tech Platforms
Immediate alerting during interventional procedures: Interventional radiology guidance platforms during ultrasound-guided hepatic cyst aspiration and sclerotherapy — real-time imaging access during needle positioning, aspiration, and sclerosant instillation is a procedural safety requirement.
Immediate alerting during laparoscopic surgery: Surgical imaging and planning platforms during laparoscopic hepatic cyst fenestration and deroofing — intraoperative access to preoperative MRCP and hepatic vascular anatomy is critical for safe fenestration margin definition.
Immediate alerting during emergency presentations: Diagnostic radiology and emergency medicine platforms during acute intracystic hemorrhage, cyst infection, torsion, and rupture evaluations — emergency access to prior imaging and acute CT interpretation determines the urgency and nature of the clinical response.
Immediate alerting during malignancy exclusion reviews: Diagnostic radiology platforms during complex cyst characterization sessions where biliary cystadenoma, cystic hepatocellular carcinoma, and cystic metastases must be excluded before simple cyst reassurance is provided.
Sustained-failure alert (10–15 minutes): Hepatology platforms for polycystic liver disease surveillance; interventional radiology scheduling for elective sclerotherapy; laparoscopic surgery scheduling for elective fenestration.
Sustained-failure alert (15–30 minutes): Patient portal reassurance and surveillance communication platforms.
30-day advance warning: SSL certificates across all domains.
Vigilmon's multi-region monitoring confirms Hepatic Cyst platform availability from the geographies where hepatology clinics, diagnostic radiology departments, interventional radiology suites, minimally invasive surgery programs, and emergency departments coordinate the imaging characterization, malignancy exclusion, procedural intervention, surgical management, and patient surveillance of patients with hepatic cysts.
Status Page for Hepatic Cyst Care Team Communication
A real-time status page gives hepatologists reviewing surveillance imaging for known simple hepatic cysts, radiologists characterizing complex hepatic lesions for malignancy exclusion before simple cyst reassurance, interventional radiologists accessing pre-procedure hepatic imaging during sclerotherapy planning, surgeons reviewing preoperative MRCP before laparoscopic cyst fenestration, emergency physicians evaluating acute hepatic cyst complications, and patient portal coordinators delivering surveillance schedules and reassurance communications immediate platform visibility without requiring IT support contact. During a diagnostic radiology platform outage when a radiologist is attempting to load contrast-enhanced CT for a patient with an ultrasound-detected hepatic lesion showing borderline complexity features — internal echogenicity and apparent wall thickening — and cannot access the CT images to determine whether the lesion represents a complicated simple cyst or a biliary cystadenoma requiring hepatobiliary surgery referral, a status page enables immediate outage identification and escalation to backup diagnostic pathways without delaying the patient's evaluation.
Include the status page URL in hepatology downtime protocols, diagnostic radiology downtime procedures, interventional radiology procedure downtime protocols, minimally invasive surgery downtime procedures, and emergency medicine downtime workflows.
Vigilmon Setup for Hepatic Cyst Tech Platforms
A practical starting configuration:
| Monitor | Check Interval | Alert Channel | |---------|----------------|---------------| | Authentication | 1 min | Slack + PagerDuty (24/7) | | Emergency medicine / acute complication | 1 min | Slack + PagerDuty (24/7) | | Diagnostic radiology / complex cyst characterization | 1 min | Slack + PagerDuty (imaging hours) | | Interventional radiology / sclerotherapy guidance | 1 min | Slack + PagerDuty (procedural hours) | | Laparoscopic surgery / fenestration imaging | 1 min | Slack + PagerDuty (operative hours) | | Hepatology / polycystic liver disease surveillance | 2 min | Slack + PagerDuty (clinic hours) | | Elective interventional scheduling | 2 min | Slack (business hours) | | Patient portal / reassurance and surveillance | 2 min | Slack + PagerDuty (business + evening hours) | | SSL: all domains | Daily | Email (30-day warning) |
Getting started:
- Create a free account at vigilmon.online
- Add authentication endpoints at 1-minute intervals with 24/7 alerting
- Configure emergency medicine platforms with 24/7 immediate alerting for acute intracystic hemorrhage, cyst infection, torsion, and rupture presentations
- Add diagnostic radiology platforms with immediate alerting during complex hepatic cyst characterization sessions — malignancy exclusion is the critical gate before simple cyst reassurance is provided
- Configure interventional radiology guidance platforms with immediate alerting during procedural hours for sclerotherapy and aspiration procedures
- Add laparoscopic surgical imaging platforms with immediate alerting during operative hours for cyst fenestration and deroofing cases
- Configure hepatology platforms with sustained-failure alerting during clinic hours for polycystic liver disease surveillance
- Add patient portal platforms with sustained-failure alerting for reassurance communication and surveillance scheduling
- Enable SSL certificate monitoring across all imaging, interventional, surgical, and patient communication domains
- Add the status page URL to hepatology, radiology, interventional radiology, surgery, and emergency medicine downtime protocols
Conclusion
Hepatic Cyst technology platforms are embedded in clinical decisions where diagnostic radiology platform availability during the characterization review of a newly detected hepatic lesion in a fifty-three-year-old woman — where the abdominal ultrasound performed for right upper quadrant discomfort demonstrates a seven-centimeter lesion with an imperceptible wall, anechoic content, and posterior acoustic enhancement that would confirm a simple benign hepatic cyst requiring only reassurance and no treatment, but where an irregular mural thickening in one quadrant of the lesion introduces diagnostic uncertainty that requires contrast-enhanced MRI to exclude biliary cystadenoma or early cystic hepatocellular carcinoma, and where the imaging platform providing that MRI is the instrument on which the entire management decision hinges — cannot be interrupted by a radiology workstation failure that prevents loading the MRI at the moment the radiologist must determine whether to issue the simple hepatic cyst diagnosis and recommend no follow-up or to recommend hepatobiliary surgery referral; where interventional radiology platform availability during an ultrasound-guided sclerotherapy procedure for a symptomatic nine-centimeter hepatic cyst in a sixty-one-year-old man — where the interventional radiologist is accessing real-time ultrasound to position the needle within the dependent portion of the cyst, aspirating the cyst contents, and preparing to instill ethanol sclerosant into the cyst cavity, and where the pre-procedure imaging stored on the interventional radiology platform contains the MRCP confirming the absence of biliary communication that is the critical safety criterion preventing biliary sclerotherapy injury — cannot be interrupted by an imaging system failure that removes pre-procedure MRCP access at the moment the sclerosant is being prepared for instillation; and where patient portal availability for the forty-eight-year-old man with autosomal dominant polycystic kidney disease and progressive polycystic liver disease who is attempting to access his surveillance imaging schedule — where the portal contains the hepatologist's recommendation for annual CT to monitor hepatomegaly progression, the nephrology coordination plan for renal function monitoring, and the symptom guide for the abdominal fullness, early satiety, and dyspnea that would warrant urgent hepatology evaluation — cannot be interrupted by a portal outage that disconnects a patient managing both hepatic and renal polycystic disease from the surveillance framework coordinating his multisystem care. A radiology platform unavailable when the simple versus complex hepatic cyst determination drives the decision between patient reassurance and oncology referral, an interventional radiology imaging system inaccessible when the biliary communication exclusion criterion protects the patient from biliary sclerotherapy injury, a polycystic liver disease surveillance platform unavailable when hepatomegaly progression determines the escalation to surgical or transplantation evaluation — these are not IT incidents. They are clinical disruptions in the management of the most common benign hepatic mass in clinical practice, where the diagnostic precision of imaging characterization, the procedural safety of percutaneous sclerotherapy, and the longitudinal accuracy of polycystic liver disease surveillance make every technology supporting the detection, diagnosis, intervention, and monitoring chain a direct determinant of whether patients with Hepatic Cyst receive the accurate, safe, and effective care this prevalent but clinically nuanced condition requires.
Uptime monitoring gives Hepatic Cyst tech teams the detection capability to identify failures within seconds, trigger immediate clinical downtime procedures, and demonstrate to hepatology departments, diagnostic radiology services, interventional radiology programs, minimally invasive surgery departments, emergency medicine services, and compliance auditors that platform operational reliability matches the imaging characterization demands, malignancy exclusion requirements, procedural guidance obligations, laparoscopic surgical planning needs, polycystic liver disease surveillance requirements, and patient communication responsibilities of modern Hepatic Cyst management.
Start monitoring your Hepatic Cyst care tech platform for free at vigilmon.online — HTTP/HTTPS monitoring, multi-region consensus alerting, SSL certificate monitoring, automatic status page, Slack and webhook alerts. No agent required. No credit card.
Tags: #monitoring #hepaticcyst #simplelivercyst #livercyst #hepaticmass #benignlivermass #polycysticliverdisease #ADPKD #biliarycystadenoma #livercystsclerotherapy #laparoscopicfenestration #hepaticcystderoofing #liverultrasound #MRCP #abdominalimaging #interventionalradiology #hepatology #HIPAA #healthtech #digitalhealth #uptime #sre